Targeted Genetics has struck a $7 million technology deal with Massachusetts-based Genzyme, extending the life of a cash-strapped Seattle biotechnology company. “We are alive and fighting and in ...
Delivering adeno-associated virus (AAV) vectors into the central nervous system (CNS) of nonhuman primates is associated with toxicity of sensory neurons in the dorsal root ganglia (DRG), which ...